This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres. The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.
Study Type
OBSERVATIONAL
Enrollment
322
Cabinet Médical
Paris, France
concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.
There was concordance if : * The result of urinary test is \< 1000 IU/L and the value of β-hCG blood measurement was \< 1000 IU/L, Or if * The result of urinary test is ≥ 1000 iu/L and the value of β-hCG blood measurement was ≥ 1000 IU/L. There was discrepancy if: * The result of urinary test is ≥ 1000 IU/L and the value of β-hCG blood measurement was \< 1000 IU/L, Or if * The result of urinary test is \< 1000 IU/L and the value of β-hCG blood measurement was ≥ 1000 IU/L.
Time frame: At the follow-up at 2-3 weeks after inclusion
Acceptability of the urinary semi-quantitative test by the patient
The analysis of the acceptability is descriptive: * The rate of patients who performed the urinary test. * Assessment of the urinary test by physicIan : very easy/easy/difficult/Impossible * The assessment by the patient: questionnaire (Have you found the explanations given sufficient for performing the test?, How did you find the carrying out of this test? What are your feelings about checking the results of the medical abortion yourself?)
Time frame: at the follow up at 2-3 weeks after the inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.